0 followers
ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline target... Read more
Jacob Chacko
Theradexå¨
1 follower
Arine
1 follower
Garuda Therapeutics
4 followers
Bill & Melinda Gates Medical Research Institute
3 followers
ALS Therapy Development Institute
3 followers
CHDI Foundation
5 followers
cGMP Validation LLC
1 follower
Mercedes Scientific
3 followers
Amgen
227 followers
Pfizer
513 followers
REVOLUTION Medicines
5 followers
Explore companies